scispace - formally typeset
H

Han Lin

Researcher at Wenzhou Medical College

Publications -  43
Citations -  870

Han Lin is an academic researcher from Wenzhou Medical College. The author has contributed to research in topics: Leydig cell & Stem cell. The author has an hindex of 13, co-authored 35 publications receiving 677 citations. Previous affiliations of Han Lin include Rockefeller University.

Papers
More filters
Journal ArticleDOI

Involvement of testicular growth factors in fetal Leydig cell aggregation after exposure to phthalate in utero

TL;DR: It is indicated that fetal exposures to DEHP have effects on FLC number, distribution, and most importantly, steroidogenic capacity and suggest that abnormal expressions of IGF1, KITL, and LIF genes may contribute to the reproductive toxicity of phthalates.
Journal ArticleDOI

Rapid mechanisms of glucocorticoid signaling in the Leydig cell.

TL;DR: Under stress conditions, glucocorticoids have rapid actions to suppress cAMP formation thus to lower testosterone production and 17beta-hydroxysteroid dehydrogenase 3 forms the coupling with 11betaHSD1 which constitutes a rapid mechanism for modulating glucOCorticoid control of testosterone biosynthesis.
Journal ArticleDOI

Deletion of the Igf1 gene: suppressive effects on adult Leydig cell development.

TL;DR: The reduced numbers of Leydig cells in the adult testes of Igf1(-/-) mice result at least in part from altered proliferation and differentiation of ALC precursor cells, but not of the stem cells that give rise to these cells.
Journal ArticleDOI

In Utero Exposure to Diethylhexyl Phthalate Affects Rat Brain Development: A Behavioral and Genomic Approach

TL;DR: The study demonstrated the changed gene expression patterns after in utero DEHP exposure might partially contribute to the deficit of cognitive function at adulthood.
Journal ArticleDOI

Curcumin as a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase 1: improving lipid profiles in high-fat-diet-treated rats.

TL;DR: Curcumin is effective for the treatment of metabolic syndrome and four novel curcumin derivatives had high potencies for inhibition of human 11 β-HSD1 with selectivity against 11β- HSD2.